What percentage of mothers with substance use disorders (SUD) experienced symptoms of PMADs?

Mothers with substance use disorders (SUD) have a significantly higher prevalence of perinatal mood and anxiety disorders (PMADs) compared to the general population. Research indicates that approximately 19.7% to 46% of mothers with SUD report experiencing symptoms of PMADs. This range highlights the substantial impact that substance use can have on a woman’s mental health during the perinatal period, emphasizing the need for comprehensive screening and support for this population.

In contrast, the other percentage ranges provided do not reflect the higher rates associated with SUD. While they may represent lower prevalence rates, they fail to capture the significant correlation between substance use and the likelihood of experiencing mood disorders. The correct range underscores the importance of awareness and intervention strategies tailored for mothers with SUD to address both their substance use and mental health needs.